AccessPak for HIV PEP Expanded with Viracept and Lenvatinib
Determining the interaction of AccessPak for HIV PEP Expanded with Viracept and Lenvatinib and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / nelfinavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Viracept
Synonyms: n.a.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Viracept-Lenvatinib Mesylate
- AccessPak for HIV PEP Expanded with Viracept-Lenvima
- AccessPak for HIV PEP Expanded with Viracept-Lenvima (14 MG Daily Dose)
- AccessPak for HIV PEP Expanded with Viracept-Lenvima (18 MG Daily Dose)
- AccessPak for HIV PEP Expanded with Viracept-Lenvima (20 MG Daily Dose)
- AccessPak for HIV PEP Expanded with Viracept-Lenvima (24 MG Daily Dose)
- Lenvatinib-Accolate
- Lenvatinib-Accretropin
- Lenvatinib-Accucaine
- Lenvatinib-AccuHist Drops
- Lenvatinib-AccuHist PDX Drops
- Lenvatinib-AccuHist PDX Syrup